Published in Eur J Endocrinol on August 01, 2002
Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate. Hum Reprod (2008) 0.82
Anovulation and ovulation induction. Hippokratia (2006) 0.75
Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med (2008) 4.33
Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod (2004) 3.57
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet (2007) 3.36
Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril (2002) 3.03
Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med (2004) 2.95
Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol (2005) 2.42
Validity of prognostic models: when is a model clinically useful? Semin Urol Oncol (2002) 2.29
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab (2003) 2.26
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod (2007) 2.11
Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril (2002) 1.78
The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev (2006) 1.75
Primary ovarian insufficiency. Lancet (2010) 1.67
The Ross procedure: a systematic review and meta-analysis. Circulation (2008) 1.65
Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. J Clin Oncol (2003) 1.63
Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab (2004) 1.61
Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power? Ann Epidemiol (2005) 1.61
Prognosis after aortic root replacement with cryopreserved allografts in adults. Ann Thorac Surg (2003) 1.59
The international agreement study on the diagnosis of the septate uterus at office hysteroscopy in infertile patients. Fertil Steril (2013) 1.51
Prediction models in reproductive medicine: a critical appraisal. Hum Reprod Update (2009) 1.50
The impact of ovarian stimulation with recombinant FSH in combination with GnRH antagonist on the endometrial transcriptome in the window of implantation. Reprod Sci (2008) 1.50
Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol (2004) 1.46
Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med (2008) 1.44
Actual and actuarial probabilities of competing risks: apples and lemons. Ann Thorac Surg (2007) 1.43
Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study. Br J Ophthalmol (2007) 1.41
A reanalysis of a reanalysis! The path to enlightenment. Fertil Steril (2002) 1.40
Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome. Hum Reprod (2013) 1.40
Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab (2008) 1.39
A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment. Fertil Steril (2007) 1.38
Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab (2004) 1.37
The prevalence of pelvic organ prolapse symptoms and signs and their relation with bladder and bowel disorders in a general female population. Int Urogynecol J Pelvic Floor Dysfunct (2009) 1.34
Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod (2004) 1.32
Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod (2007) 1.27
A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer. Fertil Steril (2002) 1.27
Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog (2010) 1.26
Balancing the strengths of systematic and narrative reviews. Hum Reprod Update (2004) 1.24
Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg (2009) 1.22
New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv (2002) 1.21
Heterogeneity bias: the difference between adjusted and unadjusted effects. Med Decis Making (2004) 1.20
A new logistic regression approach for the evaluation of diagnostic test results. Med Decis Making (2005) 1.19
Prediction model and prognostic index to estimate clinically relevant pelvic organ prolapse in a general female population. Int Urogynecol J Pelvic Floor Dysfunct (2009) 1.18
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update (2012) 1.18
Symptomatic pelvic organ prolapse and possible risk factors in a general population. Am J Obstet Gynecol (2008) 1.15
A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab (2007) 1.10
Renaming PCOS--a two-state solution. J Clin Endocrinol Metab (2013) 1.08
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod (2009) 1.08
Tackling burden in ART: an integrated approach for medical staff. Hum Reprod (2012) 1.07
Accuracy of self-reported family history is strongly influenced by the accuracy of self-reported personal health status of relatives. J Clin Epidemiol (2011) 1.07
Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril (2003) 1.06
Cox proportional hazards models have more statistical power than logistic regression models in cross-sectional genetic association studies. Eur J Hum Genet (2008) 1.02
A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril (2002) 1.02
High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod (2003) 1.01
Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod (2009) 1.01
A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine. BJU Int (2011) 1.00
Long-term outcome in couples with unexplained subfertility and an intermediate prognosis initially randomized between expectant management and immediate treatment. Hum Reprod (2011) 0.99
Prediction of an ongoing pregnancy after intrauterine insemination. Fertil Steril (2004) 0.99
Intraovarian control of early folliculogenesis. Endocr Rev (2014) 0.99
Predictive value and clinical impact of Basal follicle-stimulating hormone in subfertile, ovulatory women. J Clin Endocrinol Metab (2007) 0.98
Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode. J Thorac Cardiovasc Surg (2006) 0.98
Low folate in seminal plasma is associated with increased sperm DNA damage. Fertil Steril (2008) 0.98
Acceptable cost for the patient and society. Fertil Steril (2013) 0.97
Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update (2012) 0.97
Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update (2003) 0.96
Applicability of clinical prediction models in acute myocardial infarction: a comparison of traditional and empirical Bayes adjustment methods. Am Heart J (2005) 0.96
IVF outcomes are associated with biomarkers of the homocysteine pathway in monofollicular fluid. Hum Reprod (2009) 0.96
Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety. Fertil Steril (2011) 0.95
Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility. Reprod Biomed Online (2006) 0.95
Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population. Ann Thorac Surg (2003) 0.95
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Reprod Biomed Online (2011) 0.95
Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo. Fertil Steril (2009) 0.94
Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril (2002) 0.93
IVF outcome in anovulatory infertility (WHO group 2)--including polycystic ovary syndrome--following previous unsuccessful ovulation induction. Reprod Biomed Online (2003) 0.93
Genes involved in initial follicle recruitment may be associated with age at menopause. J Clin Endocrinol Metab (2010) 0.92
Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls. Mediators Inflamm (2007) 0.92
A comparison between low-volume referring regional centers and a high-volume referral center in quality of preoperative metastasis detection in esophageal carcinoma. Am J Gastroenterol (2006) 0.92
Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age. J Clin Endocrinol Metab (2011) 0.92
Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril (2002) 0.91
Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study. Eur J Cardiothorac Surg (2007) 0.91
Prospective validation of two models predicting pregnancy leading to live birth among untreated subfertile couples. Hum Reprod (2005) 0.91
Influence of shift work on early reproductive outcomes: a systematic review and meta-analysis. Obstet Gynecol (2014) 0.90
Body mass index is an important determinant of methylation biomarkers in women of reproductive ages. J Nutr (2009) 0.90